ACHIEVE LIFE SCIENCES, INC.
1040 West Georgia Street, Suite 1030
Vancouver, BC V6E 4H1
January 5, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: |
Ada D. Sarmento | |
Re: |
Achieve Life Sciences, Inc. Registration Statement on Form S-3 (File No. 333-269059). |
Requested Date: January 9, 2023
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Achieve Life Sciences (the Registrant) hereby requests that the Securities and Exchange Commission (the Commission) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the Requested Date and Requested Time set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes Amanda L. Rose and Steven Jean, both of whom are attorneys with the Registrants outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Rose at (206) 389-4553 or, in her absence, to Mr. Jean at (212) 430-2634.
* * *
Sincerely, |
||||
ACHIEVE LIFE SCIENCES, INC. | ||||
By: |
/s/ John Bencich | |||
John Bencich | ||||
Chief Executive Officer |
cc: | Amanda L. Rose, Esq. |
Steven Jean, Esq.
Fenwick & West LLP